Tag archief: English Only

Kite Announces New Yescarta® Data From ZUMA-1

— Sub-Population Analysis Demonstrates High Rates of Durable Response and Overall Survival Regardless of Age at Two Years Post-Treatment — — Safety Management Study Shows...

Grupo Ferroeste Saving an Estimated R$2 Million by Switching to Rimini Street Support for its SAP Application

Leading steel manufacturer in Brazil leverages substantial savings to accelerate digital transformation initiatives LAS VEGAS–(BUSINESS WIRE)– Rimini Street, Inc. (Nasdaq: RMNI), a global provider of...

TransCure bioServices Raises €2,5M Funding

New financing round will enable the company to accelerate its growth and expand its international services offer ARCHAMPS, France–(BUSINESS WIRE)– TransCure bioServices (France), a one-stop-shop...

New Ad-hoc Analysis of Phase 3 HELP Study™ Evaluates Prevention of HAE Attacks with TAKHZYRO® (lanadelumab) During Early Treatment Phase

Data Presented at European Academy of Allergy and Clinical Immunology Congress OSAKA, Japan–(BUSINESS WIRE)– Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced new data from...

IFF Completes Buyout of Remaining Shares of Wiberg Corporation

NEW YORK–(BUSINESS WIRE)– Regulatory News: International Flavors & Fragrances Inc. (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF), has completed the buyout of the remaining 50%...

Traxens to Showcase Its Multimodal Offering at Transport Logistic Exhibition in Munich

Company’s IoT solutions for maritime and rail freight implemented by major global companies MARSEILLE, France–(BUSINESS WIRE)– Traxens, a company providing high-value data and services for...

Kite Announces End of Phase 1 ZUMA-3 Results for KTE-X19 in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia

— Data Show High Rates of Response to Single Infusion of KTE-X19 — — Phase 2 Portion of ZUMA-3 is Ongoing and Includes Dosing and...

Kite and Humanigen Announce Clinical Collaboration to Evaluate Investigational Combination of Yescarta® (Axicabtagene Ciloleucel) with Lenzilumab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

— Phase 1/2 Multi-Center Clinical Trial to Begin Enrolling in Q4 2019 — SANTA MONICA, Calif. & BURLINGAME, Calif.–(BUSINESS WIRE)– Kite, a Gilead Company (Nasdaq:...

Samsung’s Exynos Auto 8890 Powers In-vehicle Infotainment System in the New Audi A4 and Upcoming Models

The Audi A4’s IVI system equipped with the Exynos Auto 8890 will be first introduced in Europe in the fall SEOUL, South Korea–(BUSINESS WIRE)– Samsung...

Gilead and Galapagos to Present Latest Data on Filgotinib at the Annual European Congress of Rheumatology (EULAR 2019)

— Phase 3 FINCH 1 and FINCH 3 Data of Filgotinib in Rheumatoid Arthritis to Be Featured in Opening Plenary and Late Breaker Sessions —...

Rimini Street’s Nancy Lyskawa Wins Female Executive of the Year

IT executive earns a gold Stevie Award for leading Rimini Street’s global client onboarding team LAS VEGAS–(BUSINESS WIRE)– Rimini Street, Inc. (Nasdaq: RMNI), a global provider...

F-star updates on FS118 Clinical Trial and Announces Presentation at ASCO 2019

Dose escalation phase of the study completed up to the maximum planned dose of 20 mg/kg without dose-limiting toxicities (DLT) to date Preliminary patient pharmacodynamic...

Alipay Reveals Trophy for Top Scorers at UEFA Nations League Finals

The Alipay Top Scorer Awards will be presented to the leading marksmen in Porto, Portugal on June 9th HANGZHOU, China–(BUSINESS WIRE)– Alipay, the world’s leading...

MX Player Uses Limelight Networks to Deliver Broadcast-Quality Experience to Millions of Viewers Watching the India Elections

Size, scale and geographic coverage mark the largest election in India SCOTTSDALE, Ariz.–(BUSINESS WIRE)– Limelight Networks, Inc. (Nasdaq: LLNW), a leading provider of edge cloud...

Gilead Sciences Appoints Johanna Mercier as Chief Commercial Officer

– Laura Hamill to Depart Gilead – FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (NASDAQ: GILD) today announced that Johanna Mercier will join the company as Chief...